chrisvoncsefalvay/vaers-outcomes huggingface dataset:
First dose of vaccine administered on 12-Oct-2021 and second dose of vaccine administered on 27-Oct-2021; FEVERS AFTER EACH VACCINE; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (FEVERS AFTER EACH VACCINE) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose of vaccine administered on 12-Oct-2021 and second dose of vaccine administered on 27-Oct-2021) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Crohn's disease and Ulcerative colitis.    Concurrent medical conditions included Crohn's disease (Moderate to severe adult) and Ulcerative colitis (Moderate to severe).   On 12-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On 12-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PYREXIA (FEVERS AFTER EACH VACCINE). On 26-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose of vaccine administered on 12-Oct-2021 and second dose of vaccine administered on 27-Oct-2021). In January 2022, PYREXIA (FEVERS AFTER EACH VACCINE) had resolved. At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose of vaccine administered on 12-Oct-2021 and second dose of vaccine administered on 27-Oct-2021) outcome was unknown.            This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  It was unknown if the patient was enrolled in a COVID-19 Vaccine Trial.  No concomitant product use was reported.   All doses of moderna vaccine given one in once.   No treatment information was provided.  The reporter's causality for the event of fevers after each vaccine with Humira (Adalimumab) was not provided.   This case was linked to MOD-2022-624407 (Patient Link).
I had a typical fever/chills and headache but then a couple days later I found a lump in my right breast which lasted about a week before going away
Information has been received from a registered nurse concerning an unknown number of patients who were vaccinated with doses of GARDASIL (lot # not reported) that might have been improperly stored. No adverse effect reported. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available.
I experienced extreme chest pain that did not subside until two months later. I was achy all over and experienced sharp pain in my chest again. I went to the ER on 03/29/2021 and the doctors checked me to a heart attack. An Ultrasound, EKG, Stress Test, and MRI. I left on my own against medical advise and went to see a Cardiologist on 07/08/2021 and another stress test was performed (came back showing normal results).
CLIENT STATED SHE WAITED THE 15 MINUTES AND THEN STARTED TO HAVE DIFFICULTY BREATHING AND DROVE AROUND TO ENTRANCE OF CLINIC. CLIENT PRESENTED WITH RAPID, SHALLOW BREATHING, SHAKING. NURSE RAN TO GET EPINEPHRINE WHILE ANOTHER STAFF MEMBER STAYED WITH CLIENT. EMT SUMMONED. EMT GAVE OXYGEN, BENADRYL & CONTINUED TO SPEAK WITH CLIENT'S MOM VIA SPEAKER PHONE AND TO REASSURE CLIENT. FAMILY MEMBER CAME TO PICK UP CLIENT FROM CLIENT.
RECEIVED FIRST DOSE OF PFIZER COVID VACCINE ON 02/26/2021. ON 02/28/21 REPORTED TO ICC FOR SINUS CONGESTION AND DRAINAGE AFTER A COVID EXPOSURE.  HAS A PENDING COVID POC TEST FROM THAT ENCOUNTER.  DIAGNOSED WITH COVID-19 AND SCHEDULED FOR OUTPATIENT BAM INFUSION.
Stabbing pains, fever and chills in upper body, changed to severe pain  3 days later changed to severe upper body pain, especially shoulder and hands
leg ache; body ache; headache; fever; rash at the site of injection; inner part of arm was swollen like half a football; A spontaneous report was received from a Consumer concerning a 83 years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events leg ache, body ache, headache, fever, rash at the site of injection, her inner part of arm was swollen like half a football.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 13 Feb 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 016M20A.)for prophylaxis of COVID-19 infection.  On an unspecified date,patient experienced leg ache, body ache, headache, fever, rash at the site of injection, Her inner part of arm was swollen like half a football.No laboratory details was provided.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome of events, leg ache, body ache, headache, fever, rash at the site of injection and peripheral swelling was considered as unknown at the time of the report.  Based MSA comment, coded Rash as Vaccination site pain
about two weeks after injections I noticed a swollen wrist that had no injury to it.  That swelling resolved but then my feet began to swell and be painful to walk on.  A few months later my right pinky finger swelled (feet continued to be an issue), then subsequent fingers swelled/painful.  Wrist then became the same, and other areas off and on.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Other HCP).  A 75-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 16Sep2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 75 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Alzheimer's" (unspecified if ongoing); "breast cancer survivor (24 years)" (unspecified if ongoing), notes: breast cancer survivor (24 years); "low blood pressure" (unspecified if ongoing); "pacemaker" (unspecified if ongoing), notes: pacemaker. The patient's concomitant medications were not reported. Past drug history included: Known allergies: codeine, reaction(s): "Allergy", notes: Known allergies: Codeine. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Nov2022, outcome "recovering" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Anti-viral details: COVID 19 Treatment with Paxlovid, Treatment start date: 16Nov2022 and Treatment stop date: 21Nov2022, Indication: Treatment of COVID-19.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information available a possible contributory role of the suspect BNT162b2 cannot be excluded for the reported events-Drug Ineffective and COVID-19
fatigue as side effect; This case was reported by a consumer via interactive digital media and described the occurrence of fatigue in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced fatigue. On an unknown date, the outcome of the fatigue was not recovered/not resolved.   It was unknown if the reporter considered the fatigue to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 02-NOV-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The reporter wanted to know how long did fatigue last as a side effect of the vaccine. Additional supportive information: The follow-up could not be possible as no contact details were available.
Dime size welt and redness where MMR injection was administered. Iced area x 15 min and given ibuprofen. Swelling did resolve. (Kept patient at office for 15-20 minutes).
Shot given high up in right deltoid within 24 hrs had tingling and numbness in right hand first 3 fingers. This has not gone away  and is only in arm thAt got vaccine.  I think the RN hit nerve from giving too high up in arm.
This spontaneous report as received from a pharmacist refers to unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored GARDASIL 9 (Lot # M035486, expiration date 05-JUN-2019, dose and route were unknown) reconstituted with sterile diluent for prophylaxis. Diluent was not involved in the temperature excursion. The temperature excursion was at 47.2 Fahrenheit for 45 minutes. Previous temperature excursion was at 47.8 Fahrenheit for 1 hour and 16 minutes. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1708USA003659: US-009507513-1708USA003660: US-009507513-1708USA001211.
Information has been received from a health professional concerning a 10 year old male who on 31-OCT-2007 was vaccinated subcutaneously into the left arm with a second dose of varicella virus vaccine live (Oka/Merck) (Lot #659064/1357U). On 02-NOV-2007, the patient developed a red area near the injection site the size of a quarter, a low grade fever and a headache. The patient recovered on an undisclosed date. Additional information is not expected.
This case was reported by a nurse via sales rep and described the occurrence of therapy non-responder in a 54-year-old female patient who received ENGERIX B adult (batch number 995J5, expiry date 6th February 2017). This case was associated with a product complaint. Co-suspect products included ENGERIX B adult (batch number F3BB3, expiry date 18th April 2017) and ENGERIX B adult (batch number 24JP3, expiry date 10th JULY 2017. On 8th January 2015, the patient received the 1st dose of ENGERIX B adult (subcutaneous). On 11th MARCH 2015, the patient received the 2nd dose of ENGERIX B adult (subcutaneous). On 8th JULY 2015, the patient received the 3rd dose of ENGERIX B adult (subcutaneous). On 10th SEPTEMBER 2015, 245 days after received ENGERIX B adult, 183 days after receiving ENGERIX B adult and 64 days after receiving ENGERIX B adult, the patient experienced therapy non-responder. On an unknown date, the patient experienced drug dose administration interval too long, drug dose administration interval too short and pharmaceutical product complaint. On an unknown date, the outcome of the therapy non-responder, drug dose administrationinterval too long, drug dose administration interval too short and pharmaceutical product complaint were unknown. The reporter considered the therapy non-responder to be possibly related to ENGERIX B adult. ENGERIX B adult and EXGERIX B adult. Additional details were as follows:The case was one of the several reports reported by an occupational nurse for patients tested negative for Hepatitis B tires following vaccination with ENGERIX B (see cases US2015GSK136757, US2015GSK136758, US2015GSK136759, US2015GSK136760, US2015GSK136761 and US2015GSK136762). The caller reported that they had their laboratory equipment recalibrated and the tests were rerun and results were same or even lower titre's. The patient concerned in this case received 1st dose of ENGERIX B adult on 8th JANURY 2015. On 11th MARCH 2015, the patient received the 2nd dose, which led to lengthening of the vaccination schedule. On 8th JULY 2015, the patient received the 3rd dose, which led to shortening of the vaccination schedule. On 10th SEPTEMBER 2015, 245 days after receiving 1st dose of ENGERIX B adult, 183 days after receiving 2nd dose of ENGERIX B adult and 64 days after receiving 3rd dose of ENGERIX B adult, the patient underwent test for Hepatitis B antibodies and it was found to be negative causing the patient to be non-responder to the therapy.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 12/18/20 pfizer,Lot#EK5730 2nd dose: 01/09/21 Pfizer,Lot# EL3248 Diagnosed covid positive:07/27/21 Symptom onset: Exposure:Home Symptoms:Asymptomatic
Immediately after the shots (the same day), he was very lethargic.  He continued to be fussy and crying non stop and his eyes were glossy and unfocused. I called the nurse on call because he was also constipated for several days after which was very unlike him.  He continued to get sicker and sicker until we took him the ER on 01/18/11 for SEVERE vomiting.  He was throwing up non stop and couldn't stop.  After he was released from the ER, he continued to worsen over the next 2 weeks.  I took him to the dr's 8 times in the next 12 days and he was finally hospitalized for pneumonia at the start of February 2011. From the day he received his shots on 01/07 until his hospitalization, he kept getting worse and worse.  He lost all control of his neck muscles and could only lay in bed all day and whimper. He had a fever on and off and was just like a ragdoll.  While in the hospital we also observed seizure like activity that we had seen shortly after the shots. We caught it on video in the hospital and the doctors told us it appeared to be febrile seizures.
After took vaccine on 7/8/21 nurses at work checked me out on 7/29/21  and informed my of my irregular heart beat which I've never before, they preformed two EKG's and said I needed to follow up with my doctor. I did a follow up appointment with my provider and she did two more EKG's and she informed me all 4 showed different readings. Referred me to a heart specialist whom I went to she preformed another EKG and scheduled a nuclear stress test for October 4th. I
came down with COVID,  tested positive for COVID-19 after getting the first dose; came down with COVID,  tested positive for COVID-19 after getting the first dose; This is a spontaneous report from a sponsored program.  A contactable consumer (patient) reported that a male patient of an unspecified age received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number and expiry date was unknown), via an unspecified route of administration on 07Mar2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had his first shot on 07Mar2021 and on an unspecified date (reported as 'last Monday'), he came down with COVID. He was tested positive for COVID-19 after getting the first dose. He was pretty much over it now. The patient's next shot is due on 28Mar2021. The patient would like to know if he can still get his second shot or if he should wait. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Immediately after the shot, I felt dizzy and started to sweat throughout my body including my hands.  I waited more than 40 minutes to see if improved but it was exactly the same. Didn't get better or worse. I did not report it immediately because it was not alarming and I did not feel bad. It was just my head that was spinning a little bit and sweating. After waiting more than 45 minutes I decided to drive home because the dizziness was not that strong. I would say it was like a 45% dizzyness if I have to calculate how I felt. The sweating passed after 4 hours and at soon as I arrived home I went to bed and relax. It is now 6:08 pm and the dizziness has improved considerably. I would calculate now about 10% of that vertigo feeling. It is getting better and better. I just wanted to point out that in no time I was feeling bad. Everything was just in my hearing labyrinth internal with balance. I also felt 20 minutes of echoing in my ears about 2 hours ago.
This spontaneous report as received from a pharmacist refers to a patient of unknown age. The RECOMBIVAX doses were exposed to 50 Fahrenheit since 07-NOV-2013. On 09-NOV-2013 the patient was vaccinated with RECOMBIVAX HB (dose, lot and expiry date were unknown). The patient had received improperly stored RECOMBIVAX. No adverse effect was reported. This is 2 of 3 reports from same reporter. Additional information has been requested.
Injection site hot/warm; Swollen in a big knot larger than an egg; Swollen in a big knot larger than an egg; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site hot/warm), VACCINATION SITE MASS (Swollen in a big knot larger than an egg) and VACCINATION SITE SWELLING (Swollen in a big knot larger than an egg) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site hot/warm), VACCINATION SITE MASS (Swollen in a big knot larger than an egg) and VACCINATION SITE SWELLING (Swollen in a big knot larger than an egg). At the time of the report, VACCINATION SITE WARMTH (Injection site hot/warm), VACCINATION SITE MASS (Swollen in a big knot larger than an egg) and VACCINATION SITE SWELLING (Swollen in a big knot larger than an egg) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medications were not reported. The treatment information was not provided. .
Morbilliform rash on face, trunck and extremitites, fever to 101 degrees F, sweats.
First started with inflamed arm where the vaccine was given, weak arm muscle, severe 4 day migraine, stiff neck, lower right back pain, and nausea. Both legs started to continuously have tingling in them. I tried a chiropractor and it was not improving the neck stiffness, lower right back pain, or tingling. I started to have very frequent urination, constipation, severe nausea, more migraines, and rashes on my abdomen with abdomen pain. My next period was 7 days late. I experienced very light slight spotting. I passed a tannish/gray, continuous, vessely, fleshy tissue with some light bleeding. It was a light period and only lasted 2 days then was gone. It was unusual because my period has never been late and is always very heavy and 7 days. I thought I had a miscarriage so I went to the ER but the pregnancy test was negative. My period has been messed up since, only lasting a couple days and very light. The tingling in my legs lifted for the most part then it rapidly spread up my left arm, the left side of my head, left face, left neck, and left chest. It occasionally would tingle in the right side of my head and right arm but not as often. When the tingling in my legs lifted my legs were so weak I could barely walk and was having great trouble. Since then I have had veins popping out everywhere that cause a rash on my wrists and arms, canker sores, organ pain below the left and right ribs, kidney pain, sores all over my scalp with hair loss, blister-like bumps on my finger, toe, and face, orangey-red calluses and dots on my palms, flashing lights and blackened vision on the sides, left chest pain that goes out toward shoulder, shortness of breath, dizziness, confusion, not thinking clearly, nerve pain in the head, leg pain, severe muscle spasms all over body, numerous and unexplainable bruises all over body, blood in mucus, alternating constipation and diarrhea, occassional blood in stool, white tissue-like lining in urine, and re-occuring bloody noses.
Information has been received from a pharmacist concerning a male patient of unknown age. On 06NOV2014 the patient was vaccinated with ZOSTAVAX (lot # K007987, expiration date 03SEP2015) 0.65 ml once, subcutaneous. The pharmacist reported that the patient received a dose of ZOSTAVAX that was stored at 10F for 144 hours. No adverse effects were reported. The outcome of the event was unknown. Additional information is expected.
Left deltoid, extending in to Shoulder with tenderness warmth and edema. Patient unable to lift arm over head.
devel red rash on extremities & abdo w/itching w/in a day p/3rd vax; rash persisted for a wk; treatment was w/antihistamines & topical cortisone;
Td given left deltoid 9/30/04. Area 2cm from injection site: red, hot, swollen 3 days after injection left arm 3.5 cm, R16cm wide. Itching started 10/05/2004.
Patient called office approximately 45 minutes after injection. Reporting pain in (L) elbow, tingling and numbness of arm with possible difficultly breathing. I advised him to seek professional care. Was treated with "steroid" injection, oral prednisone, CLARITIN D. Left ER dept approximately 11:30 am.
23JAN93 lt arm became red hot tender, swollen extending to anticubital area;
3-5 hrs s/p vaccine- soreness at injection site. About 12h s/p vaccine administered (around 9p) began to experience chills, headache, fatigue.  This persists/worsens accompanied by chills. Temp taken at 10p (99.1, my normal is 97.6) By 0150, temp up to 100.4 along with continuing alternating sweats/chills and persisting headache. 1000mg Tylenol used at 0150.  At 0240, symptoms settle a bit and got a little sleep. 0445, woke up- headache persists. Mild chills/sweats. Afebrile at 98.6. Still fatigued. At 0800 on 1/5/21, another 1000mg Tylenol used as aforementioned symptoms worsening.  Now at 1035 (time of this report), chills/sweats have settled - left with fatigue, headache, and nasal congestion.    Of note, I tested positive for COVID and was sick for about 2-3 weeks in Sep 2020.
Post vax, child complaining of swelling in left arm, afebrile. Wednesday afternoon complaining of "weakness" (mother states he couldn't walk), fever to 100F, left arm very swollen and "hard" and "tight" all the way to the elbow. Mother called MD's office and was told to wrap arm with alcohol rugs and give Tylenol. He had "stomach ache" but no N/V. He had a poor appetite and on Thursday, 4/13/00, fever increased to 103F. Absent from school 4/13/00 and 4/14/00. On 4/13/00, arm only swollen to mid-arm, not as tight. Thursday night, fever decreased to 100F and Friday was down to 99F. By Sunday there was no fever.
Initial report received from a health care professional on 10 May 2007. A female patient (age, date of birth not reported) complained of a sore, painful "lump" at the injection site and muscle aches, after she received Adacel (lot number, route, site and date of administration not provided. At the time of the report, the patient had not recovered. Same reporter as case 2007-01666.